Log In

Life Sciences Blog

Recent Posts

  • Blog: Ireland IP & Technology Law BlogCourt of Appeal confirms Morrisons’ vicarious liability for deliberate data breach caused by employeePosted on October 23, 2018 by Davinia Brennan
    The UK Court of Appeal has dismissed an appeal against the High Court’s decision that Morrisons is vicariously liable to 5,000 employees for misuse of their personal data by a rogue employee. The decision is causing shockwaves amongst businesses, as it shows that a company may be held vicariously liable for a data breach caused...Continue Reading…
    READ FULL ARTICLE
  • Blog: Waller Law BlogThe future is now at the Metro Nashville Beer BoardPosted on October 23, 2018 by William T. Cheek III
    READ FULL ARTICLE
  • Blog: Homeostasis: Dykema's Health Care Law BlogCMS to Enhance Oversight of Accrediting OrganizationsPosted on October 22, 2018 by Joanne R. Lax
    On October 4, 2018, CMS informed the public about several new enhancements to its oversight of accrediting organizations (AOs) and increased transparency regarding AO Performance. Health care providers that obtain Medicare certification via deemed status may find that AOs will be more conscientious than ever about ensuring that the provider satisfies all Medicare Conditions of Participation (COP) in addition to all AO internal standards. Read More › Tags:
    READ FULL ARTICLE
  • Blog: Biologics BlogNew Arguments in Momenta On Standing to Appeal IPR Loss Before Filing a Biosimilar ApplicationPosted on September 11, 2018 by
    In Momenta Pharmaceuticals, Inc. v. Bristol-Myers Squibb Co., No. 17-1694 (Fed. Cir. argued Dec. 5, 2017), BMS challenges Momenta’s standing to appeal a PTAB decision upholding the validity of BMS’s patent relating to a formulation of Orencia® (abatacept) in an IPR brought by Momenta before having filed a biosimilar marketing application.  The Federal Circuit is [...]
    READ FULL ARTICLE
  • Blog: EndpointsFormer FDA Counsel Joins Verrill Dana’s Health Care GroupPosted on July 16, 2018 by Academic and Clinical Research Group
    We are pleased to welcome attorney Katlin McKelvie Backfield to our nationally recognized Health Care Group. Katlin comes to Verrill Dana with more than 15 years of pharmaceutical regulatory experience, including more than a decade at the Food and Drug Administration. While at the FDA, Katlin served as Associate Chief Counsel for Drugs in the Office of Chief Counsel and as a Regulatory Counsel in the Division of Drug Marketing, Advertising, and Communications (DDMAC) (now the Office of Prescription Drug Promotion). Prior to joining [...]
    READ FULL ARTICLE

WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | DISCLAIMER |  © World Services Group, 2018